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ABSTRACT 
 
 
This MQP researched transcription factor YY1 in B-lymphocytes, which is thought to be 
a master regulator of germinal center formation. Germinal centers within lymphoid tissues are 
important areas of B-lymphocyte proliferation and differentiation, and are essential for a B-
lymphocyte immune response. This immune response was studied by creating YY1-null mice 
lacking this key transcription factor.  Using a cre/lox recombination system, mice were bred to 
become germinal center YY1-null.  Fluorescence activated cell sorting (FACS) was performed for 
germinal center surface proteins GL-7 and CD-95 to quantitate changes in germinal center 
numbers.  The results showed that stimulation of the mouse immune system with an injection of 
sheep red blood cells increases germinal center numbers, and deletion of YY1 causes germinal 
center numbers to decrease, suggesting that YY1 is important for germinal center formation.  
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BACKGROUND 
 
 
B-Cell Development and Germinal Centers 
Germinal centers (GCs) are sites within secondary lymphoid organs (such as spleen, lymph 
nodes, and intestinal Peyer’s patches) where mature B-lymphocytes proliferate, differentiate, and 
mature (MacLennan, 1994; Thorbecke et al., 1994; Natkunam, 2007; Victoria, 2014).  During an 
infection, this maturation process includes the mutation of their antibody genes (through somatic 
hyper-mutation), and the switching of antibody classes (i.e. from IgM to IgG).  Thus, GCs are 
important regions of B-lymphocyte ontogeny.   
B-lymphocytes, otherwise referred to as B-cells, are types of white bloods cells that play a 
role in antibody-mediated responses of the adaptive immune system ("Immune System B-Cells," 
2015). Adaptive immunity is a subset of the immune system that allows the body to respond and 
adapt to specific foreign antigens. This system uses highly specialized cells to allow the body to 
remember different antigens it has encountered. During an infection, B-lymphocytes become 
activated by foreign antigens and undergo many stages of differentiation. The process of B-
lymphocyte specialization and development is controlled in germinal centers.  
Germinal centers (Figure-1), consist of a light zone (diagram, upper) and dark zone 
(diagram, lower) (Natkunam, 2007). These microenvironments are temporary and only arise as a 
result of exposure to a foreign antigen from an antigen presenting cell. The germinal center 
reactions causing B-lymphocyte differentiation occur in various stages (MacLennan, 1994), and 
their length is variable lasting from 9 to 21 days post antigen exposure, peaking at about 10 days 
post exposure (Victora, 2014).  
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Figure-1: Diagram of a Germinal Center. Shown are the main processes of a germinal 
center reaction to produce mature B-lymphocytes.  The dark zone and light zone areas of 
the germinal center are shown, as well as the flow of B-lymphocytes through the 
maturation process.  Clonal expansion and class switching take place in the dark zone.  
The selection of high affinity B-lymphocytes occurs in the light zone.  (Heesters et al., 
2014) 
 
B-lymphocyte development begins with stem cells originating from the bone marrow. 
These stem cells undergo V(D)J recombination, or antigen receptor gene rearrangement, that 
results in fully functional antigen receptors on naïve B-lymphocytes through genetic 
recombination. This random recombination creates B-lymphocyte diversity and allows the cells to 
appropriately encounter antigens (Alt et al., 1992). B-lymphocytes at this stage in their 
development only secrete and present low-affinity antibodies on their surface, so they are only 
capable of binding small amounts of antigen over longer periods of time. In order for high affinity 
antibodies to be made, the naïve B-lymphocyte cells need to continue through various stages of 
specialization. Once an antigen is encountered from an antigen-presenting cell, the B-lymphocyte 
enters the germinal center microenvironment for additional proliferation and differentiation.  The 
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process of antigen presentation involves a portion of the antigen, an epitope, coupled with a major 
histocompatibility complex (MHC). Once B-lymphocytes process and present the antigen bound 
MHC on the surface of their cells, T-cells recognize these cells and deliver signals that promote 
the beginnings of B-lymphocyte proliferation and eventual differentiation (Victora, 2014). These 
critical signals cause naïve B-lymphocytes to begin rapid clonal expansion and immunoglobulin 
class switching recombination (CSR), which take place in the germinal center dark zone. 
Simultaneously, the B-lymphocytes go through AID-driven somatic hyper-mutation, an essential 
step in increasing antibody affinity. The activation-induced cytidine deaminase (AID) is a germinal 
center B-lymphocyte specific enzyme that facilitates somatic hyper-mutation. Somatic hyper-
mutation (SHM) is the introduction of non-random, single base changes in the genes encoding the 
antigen-binding sites on the surface of B-lymphocytes. This mutational process powerfully 
diversifies B-lymphocyte cells, a vital characteristic of high-affinity antigen-binding cells 
(Natkunam, 2007).  
SHM and CSR create a variety of B-lymphocyte clones within the germinal center with 
different maturation states. At this point in the B-lymphocyte differentiation process, the cells 
move into the light zone of the germinal center. The movement process is not well characterized, 
but only the highest affinity cells are selected to go into the germinal center light zone (Victora, 
2014). Affinity selection is mediated by survival signals from follicular dendritic and T-helper cell 
signals which create a cycle where cells that are unable to make it into the light zone as a result of 
low affinity go through the process again to continue gaining increased antibody affinity 
(Natkunam, 2007). Once the final differentiation stages are completed, some B-lymphocytes 
differentiate into plasma cells, others differentiate into memory B-lymphocyte cells, and others 
that are no longer functional undergo apoptosis. The entire germinal center reaction process of B-
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lymphocyte maturation peaks at about 10 days post antigen exposure, and after 21 days post 
antigen exposure the germinal centers begin to dissolve. 
Overall, the germinal centers are an important part of the B-lymphocyte humoral immune 
response, acting as factories for the production of affinity-matured B-lymphocytes that effectively 
recognize infectious agents, and for the production of durable memory B-lymphocytes 
(MacLennan, 1994; Thorbecke et al., 1994; Natkunam, 2007). 
 
YY1 Transcription Factor 
Transcription factor Ying Yang-1 (YY1) is a ubiquitous transcription factor that plays a 
role in a variety of biological processes, including cellular proliferation, differentiation, relocation, 
and embryogenesis. Contingent upon the different environments it is in, YY1 can either stimulate 
or repress transcription, but the mechanisms by which it does so have not yet been defined (Gordon 
et al., 2005).  
Some evidence exists that YY1 plays a role in B-lymphocyte development, especially in 
early development during V(D)J recombination (Liu et al., 2007).  YY1 has been postulated to be 
a master regulator of germinal center reactions. Gene expression profiling of mouse B-
lymphocytes showed that YY1 is a prominent transcription factor up-regulated in germinal center 
reactions, and is likely one of its key regulators (Green et al., 2011).  Over-expression of Smurf2 
was shown to increase ubiquitination and degradation of YY1, and suppress B-lymphocyte 
proliferation (Ramkumar et al., 2013.  
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Gene Editing Using the Cre-Lox Recombination System 
This MQP project will use two different systems for knocking out the transcription factor 
YY1 in B-lymphocytes, the Cre-lox system for in vivo knockout (KO), and the CRISPR-Cas9 
system for in vitro knockout as a negative control and B-lymphocyte in vitro stimulation.  Cre-lox 
recombination is a site-specific recombination technology that allows gene editing (insertions, 
deletions, inversions) at specific loci.  The Cre-lox system was discovered in 1988 as part of the 
P1 bacteriophage reproductive replication system (Sauer and Henderson, 1988). This system has 
been used in mammalian models for performing specific gene deletions, insertions, inversions, and 
translocations. Cre recombinase is an enzyme that catalyzes recombination between two loxP 
restriction sites, each approximately 35 base pairs in length that are inserted to flank a gene of 
interest (Figure-2). Transgenic technology is used in advance to insert loxP sites left and right of 
(flanking) the gene to be edited.  The orientation of the floxed sites, sites flanked by loxP sites, 
determines which gene is edited. Floxed sites inserted in different directions result in inversions 
of a gene (diagram, left), loxP sites inserted on different chromosomes results in gene translocation 
(diagram, center), while floxed sites in the same direction flanking a gene results in gene deletion 
(diagram, right) (The Jackson Laboratory, 2015).  
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Figure-2: Diagram of the Cre-Lox Recombination System for Gene Editing. Shown 
are different uses of cre-lox recombination for gene editing. (A) Inversion: flanking loxP 
sites face each other, (B) Translocation: loxP sites are located on different chromosomes, 
and (C) Deletion: flanking loxP sites face the same direction. (The Jackson Laboratory, 
2015) 
  
Gene Editing Using the CRISPR/Cas9 System 
Clustered regularly interspaced short palindromic repeats (CRISPR) is another gene editing 
tool that has gained widespread use in the past few years due to its high efficiency and ease of use 
(Mali et al., 2013; Shen et al., 2013; AddGene, 2014). This gene editing tool is composed of a 
specifically designed duplex guide RNA (red in the diagram) and the Cas9 endonuclease (green in 
the diagram) (Figure-3). The guide RNA is individually designed to hybridize to a sequence 
location for editing, and this binding directs the Cas9 endonuclease to the location. The Cas9 
endonuclease unwinds the DNA and cleaves the DNA causing a double-stranded break (Addgene, 
2014). The CRISPR-Cas9 system can be used to disrupt genes of interest, by either insertion or 
deletion, or can modify endogenous genomes to activate specific genes (Shen et al., 2013).  
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Figure-3: Diagram of the CRISPR/Cas9 System for Specific Gene Editing. The Cas-9 
guide RNA (gRNA) (red) is designed to recognize and hybridize to the gene of interest, 
targeting the Cas9 nuclease (green) to the location, causing a double stranded break 
(DSB).  The break is repaired, causing editing or disruption of the target gene (Addgene, 
2014). 
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PROJECT PURPOSE 
 
 Germinal centers (GCs) are sites within secondary lymphoid organs (such as spleen, lymph 
nodes, and intestinal Peyer’s patches) where mature B-lymphocytes proliferate, differentiate, and 
mature.  Although they are thought to play an important role in B-lymphocyte development, 
questions remain about exactly which pathways are involved, how the reactions work, and which 
genes and transcription factors are critical. In diseases such as diffuse large B-lymphocyte 
lymphoma, the B-lymphocytes no longer respond to standard chemotherapy, so a deeper 
understanding of B-lymphocyte maturation in the germinal center pathways could lead to effective 
therapies for B-lymphocyte diseases (Ramkumar et al., 2013).  
Transcription factor Ying Yang-1 (YY1) is thought to serve as a key regulator of B-
lymphocyte maturation in germinal centers. Gene profiling studies indicate that YY1 is a key 
regulator of germinal center reactions (Green et al., 2011).  Over-expression of Smurf2 was shown 
to increase ubiquitination and degradation of YY1, and suppress B-lymphocyte proliferation 
(Ramkumar et al., 2013.  But how YY1 regulates B-lymphocyte differentiation and proliferation, 
and by which reactions is unknown.  The purpose of this MQP project was to investigate, in vivo 
and in vitro, the relationship between YY1 and germinal center reactions by deleting the YY1 
gene, and in particular determining whether deleting the YY1 gene causes a decrease in germinal 
center numbers. In B6 mice, YY1 was conditionally deleted in germinal center B-lymphocytes 
using AID-cre/lox recombination, and also through the design of a gRNA for CRISPR/Cas9 in 
vitro usage. YY1 conditional knockout (CKO) mice were stained with fluorescent antibodies for 
B220 (a pan B-lymphocyte marker), and GL7 and CD95 germinal center surface proteins, and then 
analyzed through flow cytometry FACS analysis to quantitate GC numbers. 
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METHODS 
YY1-Null Mice  
 
All mouse studies were performed according to guidelines approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Massachusetts Medical School. 
The breeding scheme for the YY1 floxed AID-cre heterozygous experimental mice was as follows. 
Homozygous loxP-flanked YY1 mice, B6;129S4-Yy1tm2Yshi/J (The Jackson Laboratory, 2015), 
were crossed with AID-cre (AID-cre recombinase is expressed in germinal center B-lymphocytes) 
transgenic heterozygous mice, B6;FVB-Tg(Aicda-cre)1Rcas/J (The Jackson Laboratory, 2015) 
(Figure-4).  
 
 
Figure-4: Diagram of Cre-lox B-lymphocyte YY1 Knockout Strategy (Part 1). The 
figure shows the breeding scheme for B-lymphocyte specific AID-cre hemizygous mice 
(upper left) and homozygous loxP “floxed” YY1 mice (upper right). Approximately 50% 
of the offspring result in heterozygous loxP “floxed” YY1 hemizygous AID-cre, YY1 
conditional knockout, mice.  (Reproduction from The Jackson Laboratory, 2015). 
 
Offspring from this mating that were heterozygous loxP -flanked YY1 hemizygous AID-
cre mice were then backcrossed with homozygous loxP-flanked YY1 (Figure-5) to create the 
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desired homozygous loxP-flanked YY1 hemizygous AID-cre mice experimental mice. 
Homozygous loxP -flanked YY1, AID-cre nullizygous mice were used as the control.  
 
Figure-5: Diagram of Cre-lox B-lymphocyte YY1 Knockout Strategy (Part 2). 
Shown is the breeding scheme for heterozygous loxP “floxed” YY1 AID-cre hemizygous 
mice (upper left) and homozygous loxP “floxed” YY1 mice (upper right). Approximately 
25% of the offpring result in the desired homozygous loxP “floxed” YY1 hemizygous 
AID-cre, YY1 knockout mice.  (Reproduction from The Jackson Laboratory, 2015). 
 
PCR genotyping was used to confirm the genotype of the mice. Mouse tail clippings were 
used for DNA isolation, and the isolated DNA was used for genotyping PCR with YY1 and AID-
cre primers.  Primers were ordered through the University of Massachusetts Medical School 
Oligonucleotide Service (www.umassmed.edu/oligo/). 
 
Primers used for YY1 genotyping (The Jackson Laboratory, 2015):  
5’ ACC TGG TCT ATC GAA AGG AAG CAC 3’ (Forward) 
5’ GCT TCG CCT ATT CCT CGC TCA TAA 3’(Reverse) 
Primers used for AID-cre genotyping (The Jackson Laboratory, 2015):  
5’ CCG TAA CCT GGA TAG TGA AAC AG 3’ (Transgene Forward) 
5’ CCA TGC GAG TCT TAA GAT GTT G 3’(Transgene Reverse) 
5’ GTA GGT GGA AAT TCT AGC ATC ATC C 3’ (Internal Reverse) 
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Intraperitoneal (IP) Injections 
In order to boost the immune response in general, and B-lymphocyte production 
specifically, at approximately six to eight weeks of age, mice were injected intraperitoneally with 
500 µl of sheep red blood cells (SRBC) at a concentration of 1.5x109 cells per injection (Cocalico 
Biological, Inc., Stevens, PA, USA).  Three homozygous loxP “floxed” YY1 hemizygous AID-
cre, YY1 knockout, mice and three homozygous loxP -flanked YY1, AID-cre nullizygous mice 
were injected.  
Flow Cytometry Analysis 
Spleens were collected at 10 day after SRBC injections from all six injected mice and one 
non-immunized mouse. Spleens were ground between frosted glass slides, red blood cells were 
lysed, then the remaining intact splenocyte cells were filtered through a 70-μm nylon mesh and 
incubated with blocking solution, anti-CD16/32 antibody, to block Fc receptors (10 minutes on 
ice). Cells were incubated with primary monoclonal antibodies, in different groupings (Figure-6), 
for 20 minutes and washed three times with staining media [biotin-, flavin- and phenol red-
deficient RPMI-1640 medium with 10 mM, pH 7.2, HEPES, 0.02% sodium azide, 
1 mM EDTA and 2% fetal bovine serum (FBS)]. The antibodies used included B220-FITC (a pan 
B-lymphocyte marker) (1:200 dilution), and germinal center protein antibodies GL7-APC (1:100 
dilution), and CD95-PE (1:25 dilution) (Figure-6). Cells were then resuspended in 
1 μg ml−1 propidium iodide (PI) to exclude dead cells. Flow cytometry was performed on a 5-laser, 
18-detector LSR II FACS machine (BD Biosciences, San Jose, CA, USA), and the data were 
analyzed using FlowJo FACS software (Treestar, Ashland, OR, USA).  
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Sample Antibody 
1 141212A B220 GL7 CD95 
2 1478-3 B220 GL7 CD95 
3 1478-6 B220 GL7 CD95 
4 1478-10 B220 GL7 CD95 
5 1478-7 B220 GL7 CD95 
6 1478-8 B220 GL7 CD95 
7 1553-5 B220 GL7 CD95 
8 florescence  minus one 
(FMO) control 
B220 GL7  
9 florescence  minus one 
(FMO) control 
B220 CD95  
10 florescence  minus one 
(FMO) control 
CD95 GL7  
11 control PI   
12 control B220   
13 control GL7   
14 control CD95   
 
Figure-6: Table of Spleen Cell Staining. Shown are the antibodies used to stain each 
sample analyzed by the LSR II flow cytometer. Red samples are experimental samples, 
black samples are control and florescence minus one (FMO) control samples. 
 
 
CRISPR Design 
 Three guide RNAs (gRNAs) for the YY1 first exon were designed using the Zhang Lab 
CRISPR Design System, crispr.mit.edu, (MIT, Cambridge, MA, USA). The gRNAs were found 
using a human hg19 target genome and an input of YY1 Exon 1.  
YY1 Exon 1 
  
Tggcggcggagccctcagccatggcctcgggcgacaccctctacatcgccacggacggctcggagatgccggccgag
atcgtggagctgcacgagatcgaggtggagaccatcccggtggagaccatcgagaccacagtggtgggcgaggagga
ggaggaggacgacgacgacgaggacggcggcggtggcgaccacggcggcgggggcggccacgggcacgccggccacc
accaccaccaccatcaccaccaccaccacccgcccatgatcgctctgcagccgctggtcaccgacgacccgacccag
gtgcaccaccaccaggaggtgatcctggtgcagacgcgcgaggaggtggtgggcggcgacgactcggacgggctgcg
cgccgaggacggcttcgaggatcagattctcatcccggtgcccgcgccggccggcggcgacgacgactacattgaac
aaacgctggtcaccgtggcggcggccggcaagagcggcggcggcggctcgtcgtcgtcgggaggcggccgcgtcaag
aagggcggcggcaagaagagcggcaagaagagttacctcagcggcggggccggcgcggcgggcggcggcggcgccga
cccgggcaacaagaagtgggagcagaagcaggtgcagatcaagaccctggagggcgagttctcggtcaccatgtggt
cctcagatgaaaaaaaagatattgacc 
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Three separate sequences of 20 base pairs were chosen for gRNAs based on a predicted 
low number of off-target sites, high number of mismatches, and guide location not in a gene. 
Guides chosen: 
Guide #1: CTACATCGCCACGGACGGCT  
Guide #2: GTCGGGTCGTCGGTGACCAG 
Guide #3: AATGTAGTCGTCGTCGCCGC 
 
Guide RNAs and their reverse complements were ordered through the University of 
Massachusetts Medical School Oligonucleotide Service (www.umassmed.edu/oligo/). Guide 
RNA oligos were annealed to their respective reverse complements to form gRNA oligo duplexes, 
and two different sets of each guide RNA were ligated into BSMB1 digested lentiCRISPR v2 
vectors (lentiCRISPR v2 was a gift from Feng Zhang (Addgene plasmid # 52961). 8µl of ligation 
of product was transformed into 80µl of E. coli XL10 cells. Transformed cells were plated on 
ampicillin plates, colonies were selected and cultured in LB + ampicillin. QIAprep Spin Minipreps 
were performed on transformed cultures to purify plasmid DNA. Purified plasmid was sent to 
Genewiz (South Plainfield, NJ, USA) for sequencing.  
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RESULTS 
 
 
 
Germinal centers (GCs) are sites within secondary lymphoid organs (such as spleen, lymph 
nodes, and intestinal Peyer’s patches) where mature B-lymphocytes proliferate, differentiate, and 
mature.  Gene profiling studies indicate that YY1 is a key regulator of germinal center reactions 
(Green et al., 2011).  Over-expression of Smurf2 was shown to increase ubiquitination and 
degradation of YY1, and suppress B-lymphocyte proliferation (Ramkumar et al., 2013).  However, 
the pathway by which YY1 regulates B-lymphocyte differentiation and proliferation remains 
unknown.  
The purpose of this MQP project was to investigate, in vivo and in vitro, the relationship 
between YY1 and germinal center reactions by deleting the YY1 gene, and in particular to 
determine whether deleting the YY1 gene causes a decrease in germinal center numbers. In B6 
mice, YY1 was conditionally deleted in germinal center B-lymphocytes using AID-cre/lox 
recombination, and also through the design of a gRNA for CRISPR/Cas9 in vitro usage. 
Splenocytes from YY1 conditional knockout mice were stained with fluorescent antibodies for 
germinal center surface proteins, and then analyzed by flow cytometry FACS analysis to quantitate 
GC numbers. 
 
YY1 Knockout by the Cre-Recombinase System 
For the first part of this project, the YY1 gene was knocked out in germinal center B-
lymphocytes using the Cre-recombinase system.  Mice containing Cre-recombinase under the 
control of an AID promoter (to switch on Cre expression in germinal center B-lymphocytes) were 
bred to mice containing the YY1 gene flanked by LoxP sites (floxed). Splenocyte cells were 
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isolated and stained with surface antibodies conjugated with fluorescent molecules, B220-FITC 
(pan B-lymphocyte marker), and GL7-APC and CD95-PE (germinal center markers) (Figure 6). 
Cells were then run through the LSR II flow cytometer and analyzed with FlowJo software.   
Before comparative analysis of the data could be performed, each sample (Methods 
section, Figure-6), needed to undergo signal compensation and gating within the software to avoid 
any overlapping florescence to ensure the correct population of cells was being viewed. Figure-7, 
below, shows the full gating procedure on a representative sample, using mouse 1478-3.  The 
gating of all other samples was performed as described for 1478-3.  Compensation was done on 
all samples using the control and florescence minus one control samples. Compensation was used 
to set the gating, areas of interest, within the plots given the parameters of the experiment (Figure 
7). Given the experimental parameters, cells were first gated on the population of live cells based 
on propidium iodide (PI) uptake and size. Cells that contained PI and that were very small were 
excluded and the remaining population was gated on (Figure 7-1). The cells were then gated for 
forward scatter on both the X-axis and Y-axis to exclude doublet cells, clumps and debris (Figure 
7-2). Next, the cells were gated based on their complexity, side scatter verse forward scatter. This 
plot ensures the right population of cells is being selected by excluding cells that are not the correct 
size of B-lymphocytes based on granule presence within the cell (side scatter) and size (forward 
scatter) (Figure 7-3). At this point the cells were gated on the first monoclonal antibody parameter 
for pan-B-lymphocyte marker B220 staining (Figure 7-4). Cells that are B220 positive, the B-
lymphocyte population, represent a clear population that is quite distinct from cells that are B220 
negative. From the subset of B220 positive B-lymphocytes, germinal center cells can be gated on 
based on the two germinal center monoclonal antibody parameters, CD95 and GL7 (Figure 7-5). 
Double CD95/GL7+/+ positive cells represent the germinal center population being measured in 
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this project. The percentage shown in red in the upper right quadrant, is the % of GC cells of the 
live B-lymphocyte cells in that sample. 
 
Figure-7: Example of FACS Gating Using Representative Mouse 1478-3.  Shown is 
the FACS gating of immunized splenocyte cells in a YY1 fl/fl AID-Cre-Null mouse 
(1478-3).  Model gating for each sample of cells immunized with SRBCs to induce B-
lymphocyte formation. Live cell gating (1), doublet exclusion gating (2), complexity 
gating (3), B-lymphocytes-B220+ gating (4) and germinal center cells CD95/GL7+/+ 
gating (5). In this example, germinal center cells were 3.44% of live B-lymphocyte cells. 
 
 
 
 
As a negative control, one WT mouse was non-immunized (to not induce B-lymphocyte 
formation), and B220-FITC, GL7-APC, CD95-PE staining was performed as for the other 
immunized mice (Figure-8). This data shows a B-lymphocyte, B220+ population, of 60.5% and a 
very low germinal center, CD95/GL7+/+, population of 0.741% of live B-lymphocyte cells.  
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Figure-8: Non-immunized Splenocyte Control in WT Mouse. B220-FITC and CD95-
APC/GL7-PE staining of non-immunized control mouse (CD19cre/+).  In this case in 
which B-lymphocyte formation was not stimulated, the B220+ population measured at 
60.5%, and germinal center positive cells measured low at 0.741% of live B-lymphocyte 
cells. 
 
As another form of negative control, three homozygous loxP “floxed” YY1, AID-cre 
nullizygous mice (thus no YY1 gene removal) were immunized, injected with sheep red blood 
cells and analyzed by FACS (Figure-9). This data shows an average B-lymphocyte, B220+ 
population, of 66.1%, and an average germinal center CD95/GL7+/+ population of 3.26% of live 
B-lymphocyte cells.  
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Figure-9: FACS Analysis of Immunized Negative Control (YY-1 Positive) B-Cells.  
B220-FITC (B-lymphocyte) and CD95-APC/GL7-PE (germinal center) staining of 
immunized homozygous loxP “floxed” YY1, AID-cre nullizygous control mice. B220+ 
populations were 66.8%, 65.8% and 65.9%. Germinal center cell positive populations, 
CD95/GL7+/+, were 3.44%, 2.41% and 3.93% of live B-lymphocyte cells. 
 
 
The experimental group (YY1-conditional knockout mice) consisted of three homozygous 
loxP “floxed” YY1, AID-cre hemizygous mice that were immunized with sheep red blood cells 
(Figure-10). This data shows an average B-lymphocyte B220+ population of 66.2% and an average 
germinal center CD95/GL7+/+ population of 2.03% of live B-lymphocyte cells.  
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Figure-10: FACS Analysis of Immunized YY-1 Knock Out Mice.  B220-FITC and 
CD95-APC/GL7-PE staining of immunized homozygous loxP “floxed” YY1, AID-cre 
hemizygous, YY1 conditional knockout mice. B220+ populations were 69.9%, 67.8% and 
62.0%. Germinal center cell-positive populations, CD95/GL7+/+, were 1.67%, 2.87% and 
1.57% of live B-lymphocyte cells. 
 
 
The data shown above in Figure-8, Figure-9 and Figure-10 was averaged within each 
mouse population and quantified into a graph (Figure-11). Standard deviation of the averages were 
taken and represented as error bars. 
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Figure-11: Summary Graph of Germinal Center Average Percentages Per B-cell for 
Each Mouse Population. Non-immunized (n=1), immunized homozygous loxP “floxed” 
YY1, AID-cre nullizygous (n=3) (containing YY1), and immunized homozygous loxP 
“floxed” YY1, hemizygous AID-cre (n=3) (YY1 knockout) mice populations shown. 
Means of each population’s germinal center percentage was taken and depicted as well as 
standard deviation of the averages in the form of error bars. 
 
 
Overall, the non-immunized mouse (N=1) (left histobar) had a very low germinal center 
population, 0.741%, the YY1 fl/fl immunized homozygous loxP “floxed” YY1, AID-cre 
nullizygous population (middle histobar, containing YY1) had an average germinal center 
population of 3.26%, and the YY1 fl/fl AID-cre/+ immunized homozygous loxP “floxed” YY1, 
hemizygous AID-cre population (right histobar, YY1-knockout) had a reduced average germinal 
center population of 2.03%. All germinal center percentages were the population of germinal 
center cells relative to the total population of live B-lymphocyte cells. 
 
CRISPR System for YY1 Knockout 
 The second part of this project dealt with the design of a guide RNAs for CRISPR/Cas9 
usage to knockout the YY1 gene in B-lymphocyte cell lines, in vitro. The purpose of designing 
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this gRNA was for insertion into a lentiCRISPR vector and transformation into cells to create large 
quantities of lentiCRISPR plasmid with the correct gRNA insertion. After transformation of the 
lentiCRISPR, gRNA oligo duplex ligation product, sequencing of the purified plasmid from the 
transformation was conducted.  The plasmids from five different cultures were purified and sent 
for sequencing: two for the first designed guide RNA (G1A & G1B), one for the second designed 
guide RNA (G2B), and two for the third designed guide RNA (G3A & G3B). Once sequencing 
data was received, 4Peaks software (Nucleobytes, Aalsmeer, Netherlands) was used to visualize 
sequencing data and verify the insertion of the designed gRNA sequence within the five sets of 
purified plasmid. The data (Figure-12), showed that 3 of the 5 plasmid samples correctly contained 
the guide RNA within the lentiCRISPR plasmid. 
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Figure-12: Sequence Data Obtained from the Lenti-CRISPR Guide RNA Insertion 
Plasmids. Sequencing was performed to confirm the correct insertion of the guide RNA into the 
lentiCRISPR plasmid.  Three of the plasmid samples had the correct insertion of the designed 
guide RNA for the YY1 exon 1. (Guide 1, CTACATCGCCACGGACGGCT, inserted in G1A 
and G1B and Guide, GTCGGGTCGTCGGTGACCAG, inserted in G2B) 
 
 
The successful insertion of the guide RNA sequences into the lenti-CRISPR vector is 
shown in the diagram below in Figure-13. 
 
Figure-13: Diagram of the LentiCRISPR v2 Vector Containing the YY1 Guide 
RNA.  Shown is a linear view of the lentiCRISPR vector with the insertion of the YY1 
gRNA sequences shown as blue in the center of the diagram.  Different plasmid names 
and their specific YY1 target sequences are shown at their insertion sites. 
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DISCUSSION 
 
This project sought to determine whether a knockout of transcription factor YY1 had an 
effect on germinal center formation in mice. Germinal center formation and their reactions are not 
well characterized.  A deeper understanding of these reactions and how they affect B-lymphocyte 
formation could improve our understanding of antibody formation. Transcription factor YY1 was 
focused on in this research because it was previously hypothesized to be a master regulator of 
germinal center formation based on gene expression profiling (Green et al., 2011). To study 
transcription factor YY1, the YY1 gene was knocked out using an AID-cre/lox. AID-cre is a 
germinal center B-lymphocyte-specific recombination system that creates YY1 conditional 
knockout mice. Expression of the Cre-recombinase is driven by AID promoter, a gene for an 
enzyme expressed in germinal centers.  These mice were injected with sheep red blood cells to 
stimulate their immune system, and then slenocyte cells were isolated to perform FACS flow 
cytometry analysis. Slenocyte cells were stained with a pan B-lymphocyte antibody, B220, and 
germinal center specific antibodies, CD95 and GL7. Additionally, CRISPR/cas technology was 
utilized for performing the YY1 knockout.  The YY1 deletion construct was made in a 
lentiCRISPR vector to be used in the future for deletion of YY1 through the CRISPR/cas 9 system 
in vitro. 
In the first part of the project, FACS analysis was performed on various Cre mice to 
monitor germinal center B-lymphocyte numbers.  Wild Type (WT) non-immunized control mouse 
revealed a low germinal center percentage of 0.741% (percentage of germinal center positive cells 
relative to the total live B-lymphocyte cells). A low germinal center population is expected in non-
immunized mice because the B-lymphocyte cells are not presented with any antigen so they do not 
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respond, therefore little germinal center function is required. A small baseline percentage occurs, 
due to baseline immune activity, which is normal. 
Next, the FACS analysis was performed on negative control mice.  These mice were 
homozygous loxP “floxed” YY1, AID-cre nullizygous mice (YY1 fl/fl AID-cre null), that 
contained homozygous loxP “floxed” YY1 genes but no AID-cre gene to activate the “floxed” 
YY1 gene, therefore there was no YY1 deletion. Since there was no YY1 deletion, these mice 
should behave as WT mice when presented with antigen. The responses of these immunized mice 
(Figure-9) do show germinal center reaction increases relative to non-immunized mice. These 
three YY1 f/fl AID-cre null mice, 1478-3, 1478-6 and 1478-10, show a heightened germinal center 
response compared to that of the non-immunized mouse suggesting there is in fact germinal center 
responses similar to WT immunized mice. These mice had individual germinal center responses 
of 3.44%, 2.41% and 3.93%, respectively, with an average germinal center response of 3.26% 
germinal center cells of the total live B-lymphocyte cells. 
 It should be noted at an average germinal center response in an immunized WT mouse 
averages about 5-6% at day 10 after immunization (Béguelin et al., 2013). The average response 
seen here for our immunized negative control, 3.26%, is a bit low compared to the average WT 
immunized mouse. This slight difference may be due to the condition of sheep red blood cells 
injected into these mice. A follow up experiment to this one, done by the Hong Zhang lab using 
the same strain but a different stock of sheep red blood cells revealed a higher, approximately 5%, 
germinal center percentage, a more normal germinal center response to sheep red blood cell 
injection (data not shown).  
The experimental set of mice lacking YY1, homozygous loxP “floxed” YY1, AID-cre 
hemizygous mice (YY1 fl/fl AID-cre/+), behaved differently than that of the negative control YY1 
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fl/fl AID-cre-null mice. Given the decrease in germinal center positive B-lymphocytes, YY1 was 
likely deleted within the germinal center B-lymphocyte cells and germinal center reactions are 
likely affected by deletion of the YY1 gene within B-lymphocyte cells, however studies are 
ongoing to confirm these facts. Figure-10 reveals germinal center responses of the three 
immunized conditional knockout (CKO) mice, 1478-7, 1478-8 and 1553-5, to be 1.67%, 2.87% 
and 1.57%, respectively. The average germinal center response in these YY1 fl/fl AID-cre/+ mice 
was 2.03%.  This decrease in average germinal center response from 3.26% to 2.03%, though 
minimal, appears to be a decrease in germinal center formation, which suggests that the deletion 
of YY1 plays a role in germinal center formation, though what exact role YY1 plays is still 
unknown. 
Although there appears to be a difference in germinal center response in this data with YY1 
knockout, the difference was not statistically significant (Figure-11). The lack of statistical 
significance could be attributed to the low germinal center response in the immunized negative 
control due the poor condition of sheep red blood cells used for injection. In the subsequent 
experiment, referenced to earlier, a statistical significance was in fact seen between the YY1-
positive and YY1-knockout mice when the same experiment was repeated in the Zhang lab (data 
not shown).  
This FACS data, shown in this report and the unpublished Zhang lab data, suggest that the 
YY1 transcription factor does play a role as a regulator of germinal center formation, in vivo, as 
hypothesized by the gene expression profiling analysis done in 2011 (Green et al., 2011). The next 
step would be to understand and characterize exactly what role YY1 is playing in these germinal 
center formation by performing a transcriptional profile on YY1 knockout cells to deduce which 
genes are affected.  Antibody titering for this experiment was completed (data not shown). 
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With respect to the CRISPR portion of the project, the guide RNA plasmid was 
successfully constructed and verified by DNA sequencing.  Of the five purified plasmid sample 
samples submitted for sequencing, three were confirmed to contain the correct insertion of the 
designed guide RNA into the lentiCRISPR vector through the transformation process (Figure-12).  
With the successful insertion of the designed gRNAs into the lentiCRISPR vector, the next steps 
would be to package the construct into a virus for insertion into a cell line to completely delete the 
YY1 gene using the CRISPR/Cas9 system (Figure-3). Given the success of the mouse breeding 
strategy for the Cre-recombinase system, this in vitro system of deletion would act merely as a 
positive control of YY1 knockout in subsequent FACS flow cytometry experiments.  
In summary, the preliminary data outlined in this report (and supplemented by Zhang lab 
data) suggest that the YY1 transcription factor likely plays a role in germinal center formation as 
seen by the decrease in germinal center numbers after its knockout using the AID-cre/lox 
recombination system. Ongoing experimentation is currently validating the deletion of YY1 in 
germinal center cells, and further experimentation is necessary to show exactly what role the 
YY1 transcription factor plays in germinal center reactions. 
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